N-Biphenylmethyl aminocycloalkanecarboxamide derivatives

Details for Australian Patent Application No. 2003217728 (hide)

Owner Merck & Co., Inc.

Inventors Anthony, Neville J; Wood, Michael R; Feng, Dong-Mei; Wai, Jenny Miu-chun; Bock, Mark G; Kuduk, Scott D; Su, DaiShi

Agent Spruson & Ferguson

Pub. Number AU-B-2003217728

PCT Number PCT/US03/05782

PCT Pub. Number WO2003/065789

Priority 60/410,775 12.09.02 US; 60/355,062 08.02.02 US

Filing date 4 February 2003

Wipo publication date 2 September 2003

Acceptance publication date 20 November 2008

International Classifications

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/235 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4035 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/50 (2006.01) - Pyridazines

A61K 31/505 (2006.01) - Pyrimidines

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/410,775 12.09.02 US; 60/355,062 08.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2003217728

20 November 2008 Application Accepted

  Published as AU-B-2003217728

19 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217729-DISTRACTION PIN FOR FRACTURE FIXATION

2003217727-SYSTEMS AND METHODS FOR TRACKING PHARMACEUTICALS WITHIN A FACILITY